Ironwood Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Almirall EUR 741.14M 47.91M 2024-12
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 650.22M 51.62M 2024-09
Ardelyx USD 356.45M 72.35M 2024-12
Astellas Pharma JPY 1.2T 2.56B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Charles River Laboratories USD 1.51B 103.29M 2025-03
Exact Sciences USD 1.37B 201.08M 2025-03
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 6.77B 1.33B 2025-03
Myriad Genetics USD 287.2M 10.8M 2025-03
Pacira USD 759.96M 14.83M 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Takeda JPY 2.52T 233.1B 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12



Ironwood Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.